Literature DB >> 3497228

A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up.

D A Francis, D A Compston, J R Batchelor, W I McDonald.   

Abstract

One hundred and one of 146 patients presenting with isolated idiopathic optic neuritis, previously reviewed in 1978, were reassessed clinically, and retyped for HLA antigens and Factor B alleles, after a mean follow-up of 11.6 years. Fifty eight patients (57%) had developed multiple sclerosis at the time of reassessment in the present study, of whom 51 (88%) had clinically definite disease. This compared with 40% of the original group, in 1978, of whom 62% then had clinically definite multiple sclerosis. When the life-table method of analysis was used, the probability of developing multiple sclerosis was 75%, 15 years after the initial episode of optic neuritis. The frequencies of HLA-DR2 and the recently defined D-region antigen, DQw1, were significantly increased in patients with isolated optic neuritis and those who subsequently developed multiple sclerosis compared with normal controls, but neither allele appears to influence progression from optic neuritis to multiple sclerosis. Patients with optic neuritis who were HLA-DR3 positive had an increased risk for the development of multiple sclerosis (RR = 2.8) and this risk was further enhanced when DR3 occurred in combination with DR2 (RR = 6.7). The overall increased risk of developing multiple sclerosis for patients with this combination was 26 times that for the normal population. When the patients' original tissue-typing was considered BT 101 no longer influenced conversion of optic neuritis to multiple sclerosis. This may partly be explained by improved methods of tissue-typing, since not all BT 101 patients were subsequently found to be positive for HLA-DR2 or HLA-DQw1 and vice versa and by extended follow-up as multiple sclerosis conversion in HLA-DR2 negative individuals increased with time. All 101 patients were typed for Factor B alleles. No significant differences in frequencies were found between individuals with isolated optic neuritis or those who progressed to multiple sclerosis compared with the control population. Recurrent episodes of optic neuritis were associated with an increased risk for the development of multiple sclerosis in this study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497228      PMCID: PMC1032084          DOI: 10.1136/jnnp.50.6.758

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Retrobulbar neuritis. A survey of the present condition of cases occurring over the last fifty-six years.

Authors:  B H LYNN
Journal:  Trans Ophthalmol Soc U K       Date:  1959

2.  The relationship of retrobulbar neuritis to multiple sclerosis.

Authors:  R G TAUB; C W RUCKER
Journal:  Am J Ophthalmol       Date:  1954-04       Impact factor: 5.258

3.  Acute optic neuritis and the prognosis for multiple sclerosis.

Authors:  W M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-03       Impact factor: 10.154

4.  Acute unilateral retrobulbar neuritis.

Authors:  W J Collis
Journal:  Arch Neurol       Date:  1965-10

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.

Authors:  D Moulin; D W Paty; G C Ebers
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

7.  Optic neuritis and multiple sclerosis.

Authors:  G C Ebers
Journal:  Arch Neurol       Date:  1985-07

8.  Letter: HL-A and idiopathic optic neuritis.

Authors:  P Platz; L P Ryder; L S Nielsen; A Svejgaard; M Thomsen; M S Wolheim
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

9.  Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis.

Authors:  D A Compston; J R Batchelor; C J Earl; W I McDonald
Journal:  Brain       Date:  1978-09       Impact factor: 13.501

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  31 in total

Review 1.  Physicians, subsequence and consequence.

Authors:  W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Authors:  Grazyna Adamus; Lori Brown; Shayne Andrew; Roberto Meza-Romero; Gregory G Burrows; Arthur A Vandenbark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

3.  Acute Optic Neuritis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 4.  The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system.

Authors:  W I McDonald; D Barnes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

5.  Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

Authors:  N Morling; M Sandberg-Wollheim; L Fugger; J Georgsen; J J Hylding-Nielsen; H O Madsen; K Rieneck; L Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

7.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

8.  Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.

Authors:  D R Wren; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 9.  Evidence in practice--number 8. What is the prognosis of optic neuritis? How often does it lead to multiple sclerosis?

Authors:  Sharon Sanders; Chris Del Mar; Sarah Purdy; Annelise Spinks; Lisa Tait; Brian McAvoy
Journal:  Br J Gen Pract       Date:  2005-12       Impact factor: 5.386

10.  Multiple sclerosis following optic neuritis in Chile.

Authors:  G Alvarez; M Cárdenas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.